May 1, 2026
Oncology Times — Innovative Lung-MAP Trial Expands to Include More Lung Cancer Patients
Lung-MAP, a precision medicine umbrella trial for patients with advanced non-small cell lung cancer (NSCLC), has expanded genetic screening options for patients who enroll in this clinical trial of biomarker-driven therapies. The Friends of Cancer Research (Friends) hosted a webinar to explore how Lung-MAP is accelerating lung cancer discovery. “Lung-MAP has always stood out for…
Read More
